Roche’s Analyst Event at ASCO 2019
ASCO 2019 Key readouts across tumor types
Roche Oncology strategy update
Karl Mahler, Head of Investor Relations
Hematology Nancy Valente, M.D., Global Head of Product Development - Hematology Breast cancer, lung cancer & pan-tumor Alan Sandler, M.D., Global Head of Product Development - Solid Tumors
Bill Anderson, CEO Roche Pharmaceuticals

Please register to access the replay*

*Privacy notice

Roche has hosted an analyst briefing to discuss data presented on the Roche Group’s oncology products and pipeline at the American Society of Clinical Oncology Annual Meeting (ASCO) in Chicago (1 – 5 June 2018).

Past IR Events
View more Events


Related links